The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth

PURPOSE: Exposure to the polyphenolic plant lignan secoisolariciresinol diglucoside (SDG) and its metabolite enterolactone (ENL) has been associated with reduced breast cancer progression, particularly for estrogen receptor alpha (ERα)-negative disease, and decreased preclinical mammary tumor growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowers, Laura W., Lineberger, Claire G., Ford, Nikki A., Rossi, Emily L., Punjala, Arunima, Camp, Kristina K., Kimler, Bruce K., Fabian, Carol J., Hursting, Stephen D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394576/
https://www.ncbi.nlm.nih.gov/pubmed/30367332
http://dx.doi.org/10.1007/s10549-018-5021-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394576/
https://www.ncbi.nlm.nih.gov/pubmed/30367332
http://dx.doi.org/10.1007/s10549-018-5021-6

Ejemplares similares